DOJ must intervene to dismiss FCA qui tam suits, Supreme Court says, U.S. v. Executive Health Resources, Thomson Reuters WestLaw Journal Class Action, comment from Abbye Alexander, Esq., 8-9-2023

Abbye Alexander, Co-Chair of Kaufman Dolowich’s Health Care Practice Group was quoted on the Supreme Court’s decision in United States ex. Rel. Polansky v. Executive Health Resources Inc. et al, No. 21-1052, 2023 WL 4034314 (U.S. June 16, 2023), featured in ““DOJ must intervene to dismiss FCA qui tam suits, Supreme Court says U.S. v. Executive Health Resources,” Thomson Reuters 30 No. 07 Westlaw Journal Class Action 29.

” This decision protects health care defendants who should not be forced to defend actions – at great financial and reputational cost – brought on behalf of the government that the DOJ does not think should proceed. Further, this decision will help usher in a uniformed standard and consistency across the circuits…and may bring more predictable outcomes to those within the health care industry faced with unwarranted qui tam litigation.”